Speakers

Sven Kili

Chief Executive Officer • Antion Biosciences

Dr Sven Kili is Chief Executive Officer at Antion Biosciences, a Multiplex Cell Engineering company developing ‘Smart-Data’ driven in-vivo allogeneic cell therapies for underserved patients suffering from recalcitrant diseases. He was previously the Head of Development for the Cell and Gene Therapy division of GSK Rare Diseases where he led teams developing and commercialising Gene Therapies for a variety of rare genetic disorders including Strimvelis®, the first ex-vivo gene therapy to be approved for children with ADA-SCID; Wiskott – Aldrich syndrome (WAS); Metachromatic Leukodystrophy (MLD) and Beta-Thalassemia. Prior to this, he was Senior Director, Cell Therapy and Regenerative Medicine for Sanofi (Genzyme) Biosurgery where he led the clinical development, approval and commercialisation activities of the first combined ATMP product in the EU for MACI®.

Also speaking

Avencia Sanchez-Mejias

Co-Founder and CEO • Integra Therapeutics

Daniella Kranjac

Founder • Dynamk Capital

Michael von Forstner

Senior Medical Director, Global Head of Patient Safety and Pharmacovigilance, Biosimilars • Biogen

Event Info

Image

Event Brochure

Take a look at the 2023 Event Brochure for Advanced Therapies Europe.
Image

Download the 2023 Speaker List

Download the 2023 Speaker List for Advanced Therapies Europe here.